Gainers
- Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4.1 during Tuesday's pre-market session. The market value of their outstanding shares is at $11.9 million.
- Viridian Therapeutics (NASDAQ:VRDN) shares increased by 27.38% to $17.91. The market value of their outstanding shares is at $1.4 billion. As per the press release, Q1 earnings came out today.
- Cytokinetics (NASDAQ:CYTK) shares increased by 26.95% to $83.86. The market value of their outstanding shares is at $8.2 billion. The company's, Q1 earnings came out today.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 24.99% to $3.9. The market value of their outstanding shares is at $10.1 million.
- Edgewise Therapeutics (NASDAQ:EWTX) stock rose 20.82% to $38.0. The market value of their outstanding shares is at $3.3 billion.
- Regentis Biomaterials (AMEX:RGNT) shares increased by 17.64% to $3.0. The company's market cap stands at $13.2 million.
Losers
- GeneDx Holdings (NASDAQ:WGS) stock fell 41.9% to $39.48 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q1 earnings report came out yesterday.
- Embecta (NASDAQ:EMBC) stock decreased by 31.9% to $6.3. The company's market cap stands at $547.7 million. As per the news, the Q2 earnings report came out today.
- Picard Medical (AMEX:PMI) stock decreased by 29.6% to $0.25. The company's market cap stands at $26.5 million.
- CNS Pharmaceuticals (NASDAQ:CNSP) shares decreased by 23.35% to $6.01. The market value of their outstanding shares is at $6.3 million.
- Akanda (NASDAQ:AKAN) stock declined by 22.41% to $31.88. The company's market cap stands at $21.9 million.
- Lunai Bioworks (NASDAQ:LNAI) shares declined by 18.98% to $0.26. The company's market cap stands at $11.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment